Verges 2014.

Methods	Randomised cross‐over double‐blinded placebo‐controlled trial
Participants	Patients with statin‐treated type 2 diabetes
Interventions	40 mg/d long‐acting resveratrol vs placebo
Outcomes	Changes in weight, HbA1c; lipid changes
Study details	Two 3‐month periods
Publication details	Conference abstract
Stated aim of study	To study the effect of resveratrol on plasma lipids in patients with type 2 diabetes
Notes	This is a conference abstract with no author contact information provided to obtain study data

3MS: Modified Mini Mental State Examination, AC: arterial compliance, BMI: body mass index, BP: blood pressure, CVR: cerebral vasodilator responsiveness, HbA1c: glycosylated haemoglobin A1c, MCA: middle cerebral artery, TCD: transcranial doppler, T2DM: type 2 diabetes mellitus.